REGN7945+Linvoseltamab clinical trials

A Study to Assess the Safety and Anti-Tumor Activity of REGN7945 in Combination With Linvoseltamab in Adult Participants With Relapsed/Refractory Multiple Myeloma

This study is testing two experimental drugs, REGN7945 and linvoseltamab, for advanced multiple myeloma that has come back. We want to see if combining them is safe and helps more than linvoseltamab alone.